Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan flag Jordan · Delayed Price · Currency is JOD
1.550
0.00 (0.00%)
At close: Feb 8, 2026

ASE:PHIL Balance Sheet

Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1.61.651.41.51.661.6
Cash & Short-Term Investments
1.61.651.41.51.661.6
Cash Growth
6.35%18.11%-6.64%-9.82%3.74%29.99%
Accounts Receivable
6.786.386.456.246.78.66
Other Receivables
0.07--0.070.070.01
Receivables
6.866.386.456.316.788.66
Inventory
1.981.91.891.421.662.12
Prepaid Expenses
0.280.160.180.140.110.15
Other Current Assets
0.090.150.190.030.030.04
Total Current Assets
10.810.2410.129.3910.2412.58
Property, Plant & Equipment
2.862.882.062.292.392.38
Other Intangible Assets
----2.440.05
Long-Term Deferred Charges
3.333.553.854.14--
Total Assets
16.9916.6716.0315.8215.0715.01
Accounts Payable
1.241.231.351.131.091.22
Accrued Expenses
0.360.140.240.280.220.24
Short-Term Debt
0.60.671.491.831.451.65
Current Portion of Long-Term Debt
0.630.48----
Current Income Taxes Payable
0.190.140.130.10.080.01
Other Current Liabilities
0.050.140.060.090.110.44
Total Current Liabilities
3.062.793.283.442.943.56
Long-Term Debt
0.740.84----
Total Liabilities
3.813.633.283.442.943.56
Common Stock
7.57.57.57.57.57.5
Retained Earnings
5.685.545.244.894.633.95
Shareholders' Equity
13.1813.0412.7412.3912.1311.45
Total Liabilities & Equity
16.9916.6716.0315.8215.0715.01
Total Debt
1.971.991.491.831.451.65
Net Cash (Debt)
-0.37-0.33-0.09-0.330.21-0.04
Net Cash Per Share
-0.05-0.04-0.01-0.040.03-0.01
Filing Date Shares Outstanding
7.57.57.57.57.57.5
Total Common Shares Outstanding
7.57.57.57.57.57.5
Working Capital
7.737.456.835.967.39.02
Book Value Per Share
1.761.741.701.651.621.53
Tangible Book Value
13.1813.0412.7412.399.6911.4
Tangible Book Value Per Share
1.761.741.701.651.291.52
Land
1.051.050.120.120.120.12
Buildings
1.641.641.61.591.591.58
Machinery
3.83.823.733.673.583.43
Source: S&P Global Market Intelligence. Standard template. Financial Sources.